مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2.
Normal view MARC view ISBD view

Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. [electronic resource]

By:
  • Duncton, Matthew A J
Contributor(s):
  • Piatnitski Chekler, Eugene L
  • Katoch-Rouse, Reeti
  • Sherman, Dan
  • Wong, Wai C
  • Smith, Leon M
  • Kawakami, Joel K
  • Kiselyov, Alexander S
  • Milligan, Daniel L
  • Balagtas, Chris
  • Hadari, Yaron R
  • Wang, Ying
  • Patel, Sheetal N
  • Rolster, Robin L
  • Tonra, James R
  • Surguladze, David
  • Mitelman, Stan
  • Kussie, Paul
  • Bohlen, Peter
  • Doody, Jacqueline F
Producer: 20090327Description: 731-40 p. digitalISSN:
  • 1464-3391
Subject(s):
  • Administration, Oral
  • Animals
  • Biological Availability
  • Female
  • Isoquinolines -- chemical synthesis
  • Mice
  • Mice, Inbred Strains
  • Phthalazines -- administration & dosage
  • Piperidines
  • Quinazolines
  • Vascular Endothelial Growth Factor Receptor-1 -- antagonists & inhibitors
  • Vascular Endothelial Growth Factor Receptor-2 -- antagonists & inhibitors
Online resources:
  • Available from publisher's website
In: Bioorganic & medicinal chemistry vol. 17
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2.

APA

Duncton M. A. J., Piatnitski Chekler E. L., Katoch-Rouse R., Sherman D., Wong W. C., Smith L. M., Kawakami J. K., Kiselyov A. S., Milligan D. L., Balagtas C., Hadari Y. R., Wang Y., Patel S. N., Rolster R. L., Tonra J. R., Surguladze D., Mitelman S., Kussie P., Bohlen P. & Doody J. F. (20090327). Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. : Bioorganic & medicinal chemistry.

Chicago

Duncton Matthew A J, Piatnitski Chekler Eugene L, Katoch-Rouse Reeti, Sherman Dan, Wong Wai C, Smith Leon M, Kawakami Joel K, Kiselyov Alexander S, Milligan Daniel L, Balagtas Chris, Hadari Yaron R, Wang Ying, Patel Sheetal N, Rolster Robin L, Tonra James R, Surguladze David, Mitelman Stan, Kussie Paul, Bohlen Peter and Doody Jacqueline F. 20090327. Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. : Bioorganic & medicinal chemistry.

Harvard

Duncton M. A. J., Piatnitski Chekler E. L., Katoch-Rouse R., Sherman D., Wong W. C., Smith L. M., Kawakami J. K., Kiselyov A. S., Milligan D. L., Balagtas C., Hadari Y. R., Wang Y., Patel S. N., Rolster R. L., Tonra J. R., Surguladze D., Mitelman S., Kussie P., Bohlen P. and Doody J. F. (20090327). Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. : Bioorganic & medicinal chemistry.

MLA

Duncton Matthew A J, Piatnitski Chekler Eugene L, Katoch-Rouse Reeti, Sherman Dan, Wong Wai C, Smith Leon M, Kawakami Joel K, Kiselyov Alexander S, Milligan Daniel L, Balagtas Chris, Hadari Yaron R, Wang Ying, Patel Sheetal N, Rolster Robin L, Tonra James R, Surguladze David, Mitelman Stan, Kussie Paul, Bohlen Peter and Doody Jacqueline F. Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. : Bioorganic & medicinal chemistry. 20090327.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site